Mitigating Construction Risks: Nuclear Power Plants and their Environment
Ybl Journal of Built Environment · 2025
DOI: 10.12700/jbe-2025-0010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ybl Journal of Built Environment, 2025. Verfasst von Eszter Horváth-Kálmán und 2 weiteren Autor:innen.
Abstract (Originalsprache)
In this paper, we would like to assess the issue of construction risks in a nuclear power plant and the possibility of mitigating these risks through a real-time monitoring system. In our research, we are concerned with the determination of the risks of deep construction activities and their impact on a specific nuclear site. We will also investigate possible risk mitigation activities that can be used in the nuclear power plant environment and their effectiveness. In some respects, the risk analysis applied to construction projects differs from the risk analysis applied to nuclear installations. For nuclear installations, the risk as such is primarily nuclear risk. In view of this, for investments involving a nuclear installation, the risk analysis to be carried out must be carried out at two separate levels. The first level is the traditional construction risk analysis, and then on a second level, each risk item should be classified from a nuclear risk point of view. In this study, the nuclear exposure of construction risks will be presented.
Zitieren
APA
Horváth-Kálmán, E., Horváth, T., & Elek, B. (2025). Mitigating Construction Risks: Nuclear Power Plants and their Environment. Ybl Journal of Built Environment. https://doi.org/10.12700/jbe-2025-0010
Vancouver
Horváth-Kálmán E, Horváth T, Elek B. Mitigating Construction Risks: Nuclear Power Plants and their Environment. Ybl Journal of Built Environment. 2025. doi:10.12700/jbe-2025-0010
BibTeX
@article{HorvthKlmn2025,
author = {Horváth-Kálmán, Eszter and Horváth, Tibor and Elek, Barbara},
title = {Mitigating Construction Risks: Nuclear Power Plants and their Environment},
journal = {Ybl Journal of Built Environment},
year = {2025},
doi = {10.12700/jbe-2025-0010}
}
EUVIMED